Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

by Chong, Dawn qingqing, Toh, Xinyi, Ho, Ivyaw, Sia, Kianchuan, Newman, Jennifer P., Yulyana, Yulyana, Ng, Waihoe, Lai, Sianghui, Ho, Mac M F, Dinesh, Nivedh, Tham, Cheekian, Lam, Yeng Po Paula
Published 2016